+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gut Microbiota Market by Product, Indication, Application, Distribution Channel - Global Forecast to 2030- Product Image
Gut Microbiota Market by Product, Indication, Application, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Gut Microbiota Market by Product, Indication, Application, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6090143
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Gut Microbiota Market is entering a new phase of opportunity, driven by sustained cross-disciplinary innovation and increased recognition of the gut’s role in holistic human health. Senior decision-makers can capitalize on a landscape where scientific breakthroughs, regulatory shifts, and advanced consumer demands converge to open actionable routes for both short- and long-term growth.

Market Snapshot: Gut Microbiota Market Size & Growth Trends

The gut microbiota market grew from USD 856.83 million in 2024 to USD 940.37 million in 2025. It is expected to continue at a CAGR of 10.04%, reaching USD 1.52 billion by 2030. Robust technological adoption and evolving commercial dynamics continue to shape market development, underscoring resilience across product innovation, regional spread, and stakeholder engagement.

Scope & Segmentation

This market research provides comprehensive coverage of global gut microbiota applications, spanning innovative therapeutics, functional foods, and advanced supplements. Key areas include:

  • Product Types: Drugs, Prebiotics, Probiotics, Supplements
  • Indications: Allergies, Autoimmune Disorder, Diabetes, Inflammatory Bowel Disease, Irritable Bowel Syndrome, Obesity
  • Applications: Cardiovascular Health, Digestive Health, Immune Health, Mental Health, Weight Management
  • Distribution Channels: Offline Retail, Online Retail
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Company Developments: Analysis includes Abbott Laboratories, Astellas Pharma Inc., Axial Therapeutics, Inc., BioGaia USA, Inc., BiomX Inc., Danone S.A., Enterome, Finch Therapeutics Group, Inc, International Flavors & Fragrances Inc., Johnson & Johnson Services, Inc., Nestlé S.A, Pfizer Inc., Probi AB, Seed Health, Inc, Seres Therapeutics, Inc., Sun Genomics, Inc., Synlogic, Inc., Vedanta Biosciences, Inc., Viome Life Sciences, Inc, Yakult Honsha Co., Ltd.
  • Technologies Covered: Machine learning for strain selection, digital health engagement, bioprocessing innovations, personalized microbial consortia

Key Takeaways for Decision-Makers

  • Precision microbiome modulation is redefining therapeutic and functional ingredient development, expanding beyond digestive health to key areas such as immune resilience, metabolic regulation, and mental wellness.
  • Emerging partnerships between clinical institutions and industry leaders are accelerating the validation and approval of innovative products by harnessing real-world evidence and updated regulatory guidance.
  • The rise of digitally enabled health platforms enhances end-user engagement, education, and adherence—offering new opportunities for differentiation and customer retention among tech-savvy demographics.
  • Manufacturers pursuing supply chain transparency and traceability will gain competitive advantage, particularly in light of dynamic trade environments and evolving quality standards.
  • Personalized product offerings, driven by advanced sequencing and predictive analytics, are becoming central to major players’ R&D pipelines and market entry strategies.
  • Collaborative innovation with contract research and manufacturing organizations amplifies value creation and reduces time to market for advanced formulations.

Tariff Impact: 2025 US Tariff Implications

With new United States tariffs slated for 2025, companies in the gut microbiota market must anticipate cost pressures across imported strains, production media, and packaging. Vertically integrated firms and those proactively diversifying supplier networks are better positioned to buffer margin compression and supply interruptions. Reshoring strategies and partnerships with domestic biologics facilities may be necessary to ensure continuous access to premium microbial cultures. Scenario planning, strategic inventory management, and investment in visibility tools are effective ways to maintain resilience amid shifting trade policies.

Methodology & Data Sources

Research combines peer-reviewed journals, clinical trial repositories, regulatory directives, and expert interviews to ensure robust analysis. Quantitative insights are synthesized with proprietary databases tracking partnerships, patents, and M&A activity across the microbiome landscape.

Why This Report Matters

  • Enables evidence-based strategic decisions by mapping technology, regulatory, and consumer trends across major regional and industry segments.
  • Supports resilient supply chains and compliance by outlining imminent tariff impacts and evolving quality benchmarks.

Senior leaders gain a comprehensive framework for investment, innovation, and expansion within a dynamic and competitive gut microbiota market.

Conclusion

The gut microbiota market is poised for ongoing growth fueled by scientific advances, regulatory responsiveness, and rising end-user sophistication. Proactive engagement and data-driven strategies position stakeholders to harness emerging opportunities and build sustainable advantage in this evolving sector.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gut Microbiota Market, by Product
8.1. Introduction
8.2. Drugs
8.3. Prebiotics
8.4. Probiotics
8.5. Supplements
9. Gut Microbiota Market, by Indication
9.1. Introduction
9.2. Allergies
9.3. Autoimmune Disorder
9.4. Diabetes
9.5. Inflammatory Bowel Disease
9.6. Irritable Bowel Syndrome
9.7. Obesity
10. Gut Microbiota Market, by Application
10.1. Introduction
10.2. Cardiovascular Health
10.3. Digestive Health
10.4. Immune Health
10.5. Mental Health
10.6. Weight Management
11. Gut Microbiota Market, by Distribution Channel
11.1. Introduction
11.2. Offline Retail
11.3. Online Retail
12. Americas Gut Microbiota Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Gut Microbiota Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Gut Microbiota Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Abbott Laboratories
15.3.2. Astellas Pharma Inc.
15.3.3. Axial Therapeutics, Inc.
15.3.4. BioGaia USA, Inc.
15.3.5. BiomX Inc.
15.3.6. Danone S.A.
15.3.7. Enterome
15.3.8. Finch Therapeutics Group, Inc
15.3.9. International Flavors & Fragrances Inc.
15.3.10. Johnson & Johnson Services, Inc.
15.3.11. Nestlé S.A
15.3.12. Pfizer Inc.
15.3.13. Probi AB
15.3.14. Seed Health, Inc
15.3.15. Seres Therapeutics, Inc.
15.3.16. Sun Genomics, Inc.
15.3.17. Synlogic, Inc.
15.3.18. Vedanta Biosciences, Inc.
15.3.19. Viome Life Sciences, Inc
15.3.20. Yakult Honsha Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. GUT MICROBIOTA MARKET MULTI-CURRENCY
FIGURE 2. GUT MICROBIOTA MARKET MULTI-LANGUAGE
FIGURE 3. GUT MICROBIOTA MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GUT MICROBIOTA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GUT MICROBIOTA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GUT MICROBIOTA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GUT MICROBIOTA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GUT MICROBIOTA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GUT MICROBIOTA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GUT MICROBIOTA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GUT MICROBIOTA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GUT MICROBIOTA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GUT MICROBIOTA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GUT MICROBIOTA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GUT MICROBIOTA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GUT MICROBIOTA MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GUT MICROBIOTA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GUT MICROBIOTA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GUT MICROBIOTA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GUT MICROBIOTA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GUT MICROBIOTA MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GUT MICROBIOTA MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GUT MICROBIOTA MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GUT MICROBIOTA MARKET SIZE, BY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GUT MICROBIOTA MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GUT MICROBIOTA MARKET SIZE, BY AUTOIMMUNE DISORDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GUT MICROBIOTA MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GUT MICROBIOTA MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GUT MICROBIOTA MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GUT MICROBIOTA MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GUT MICROBIOTA MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GUT MICROBIOTA MARKET SIZE, BY DIGESTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GUT MICROBIOTA MARKET SIZE, BY IMMUNE HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GUT MICROBIOTA MARKET SIZE, BY MENTAL HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GUT MICROBIOTA MARKET SIZE, BY WEIGHT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GUT MICROBIOTA MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GUT MICROBIOTA MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS GUT MICROBIOTA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES GUT MICROBIOTA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. CANADA GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. CANADA GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. CANADA GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. CANADA GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. MEXICO GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. MEXICO GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. MEXICO GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. MEXICO GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA GUT MICROBIOTA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. UNITED KINGDOM GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. UNITED KINGDOM GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. UNITED KINGDOM GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. UNITED KINGDOM GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. GERMANY GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. GERMANY GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 64. GERMANY GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. GERMANY GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. FRANCE GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. FRANCE GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. FRANCE GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. FRANCE GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. RUSSIA GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. RUSSIA GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. RUSSIA GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. RUSSIA GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. ITALY GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. ITALY GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 76. ITALY GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. ITALY GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. SPAIN GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. SPAIN GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. SPAIN GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. SPAIN GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. UNITED ARAB EMIRATES GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. UNITED ARAB EMIRATES GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. UNITED ARAB EMIRATES GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. UNITED ARAB EMIRATES GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. SAUDI ARABIA GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. SAUDI ARABIA GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. SAUDI ARABIA GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. SOUTH AFRICA GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. SOUTH AFRICA GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 92. SOUTH AFRICA GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. SOUTH AFRICA GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. DENMARK GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. DENMARK GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 96. DENMARK GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. DENMARK GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. NETHERLANDS GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. NETHERLANDS GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. NETHERLANDS GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. QATAR GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. QATAR GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. QATAR GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. QATAR GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. FINLAND GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. FINLAND GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. FINLAND GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. FINLAND GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. SWEDEN GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. SWEDEN GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. SWEDEN GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. SWEDEN GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. NIGERIA GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. NIGERIA GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 116. NIGERIA GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. NIGERIA GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. EGYPT GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. EGYPT GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. EGYPT GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. EGYPT GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. TURKEY GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. TURKEY GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. TURKEY GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. TURKEY GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. NORWAY GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. NORWAY GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. NORWAY GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. NORWAY GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. POLAND GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. POLAND GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. POLAND GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. POLAND GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. SWITZERLAND GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. SWITZERLAND GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. SWITZERLAND GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC GUT MICROBIOTA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 147. CHINA GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. CHINA GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 149. CHINA GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. CHINA GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. INDIA GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. INDIA GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 153. INDIA GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. INDIA GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. JAPAN GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. JAPAN GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 157. JAPAN GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. JAPAN GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. AUSTRALIA GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. THAILAND GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. THAILAND GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 173. THAILAND GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. THAILAND GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. MALAYSIA GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. MALAYSIA GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. MALAYSIA GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. MALAYSIA GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. SINGAPORE GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. SINGAPORE GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. TAIWAN GUT MICROBIOTA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. TAIWAN GUT MICROBIOTA MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN GUT MICROBIOTA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN GUT MICROBIOTA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. GUT MICROBIOTA MARKET SHARE, BY KEY PLAYER, 2024
TABLE 196. GUT MICROBIOTA MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Gut Microbiota market report include:
  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Axial Therapeutics, Inc.
  • BioGaia USA, Inc.
  • BiomX Inc.
  • Danone S.A.
  • Enterome
  • Finch Therapeutics Group, Inc
  • International Flavors & Fragrances Inc.
  • Johnson & Johnson Services, Inc.
  • Nestlé S.A
  • Pfizer Inc.
  • Probi AB
  • Seed Health, Inc
  • Seres Therapeutics, Inc.
  • Sun Genomics, Inc.
  • Synlogic, Inc.
  • Vedanta Biosciences, Inc.
  • Viome Life Sciences, Inc
  • Yakult Honsha Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 940.37 Million
Forecasted Market Value ( USD ) by 2030 $ 1520 Million
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Barrett's Esophagus. The 10th OESO World Congress Proceedings, Volume 1232. Edition No. 1. Annals of the New York Academy of Sciences - Product Image

Barrett's Esophagus. The 10th OESO World Congress Proceedings, Volume 1232. Edition No. 1. Annals of the New York Academy of Sciences

  • Book
  • 252 Pages
  • Global, United States Global, United States
The Gut Microbiota in Health and Disease. Edition No. 1 - Product Image

The Gut Microbiota in Health and Disease. Edition No. 1

  • Book
  • 272 Pages
Gut Microbiota. Interactive Effects on Nutrition and Health - Product Image

Gut Microbiota. Interactive Effects on Nutrition and Health

  • Book
Gut Microbiota in Neurologic and Visceral Diseases - Product Image

Gut Microbiota in Neurologic and Visceral Diseases

  • Book
The microbiome: Interactions with organ systems, diet, and genetics, An Issue of Gastroenterology Clinics of North America. Clinics Review Articles: Gastroenterology - Product Image

The microbiome: Interactions with organ systems, diet, and genetics, An Issue of Gastroenterology Clinics of North America. Clinics Review Articles: Gastroenterology

  • Book
  • North America
Copyright © 2002-2025 Research and Markets. All Rights Reserved.